Iron, Plasma Antioxidants, and the ‘Oxygen Radical Disease of Prematurity’

American Journal of Diseases of Children

Volumn 142, Issue 12, 1988, Pages 1341-1344

  Sullivan, Jerome L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; APOTRANSFERRIN; CERULOPLASMIN; DEFEROXAMINE; OXYGEN; OXYGEN RADICAL;

BRAIN HEMORRHAGE; HUMAN; LUNG DYSPLASIA; NECROTIZING ENTERITIS; NEWBORN; OXYGEN POISONING; PRELIMINARY COMMUNICATION; PREMATURITY; PRIORITY JOURNAL; RETINOPATHY; REVIEW; THEORETICAL STUDY;

ANTITOXINS; APOPROTEINS; CERULOPLASMIN; FREE RADICALS; HUMAN; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; IRON; OXYGEN; TRANSFERRIN;

EID: 0024157193     PISSN: 0002922X     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpedi.1988.02150120095048     Document Type: Article

References (34)

1. Saugstad OD: Hypoxanthine as an indicator of hypoxia: Its role in health and disease through free radical production. Pediatr Res 1988;23: 143-150.
2. Dormandy TL: Free-radical oxidation and antioxidants. Lancet 1978;1: 647-650.
3. Phelps DL, Rosenbaum AL, Isenberg SJ, et al: Tocopherol efficacy and safety for preventing retinopathy of prematurity: A randomized, controlled, double-masked trial. Pediatrics 1987; 79: 489-500.
4. Hittner HM, Speer ME, Rudolph AJ, et al: Retrolental fibroplasia and vitamin E in the preterm infant: Comparison of oral versus intramuscular:oral administration. Pediatrics 1984; 73: 238-249.
5. Sullivan JL: Retinopathy of prematurity and iron: A modification of the oxygen hypothesis. Pediatrics 1986;78: 1171-1172.
6. Sullivan JL: Serum antioxidant activity in neonates. Arch Dis Child 1988;63: 748-750.
7. Stocks J, Gutteridge JMC, Sharpe RJ, et al: Assay using brain homogenate for measuring the antioxidant activity of biological fluids. Clin Sci 1974;47: 215-222.
8. Stocks J, Gutteridge JMC, Sharp RJ, et al: The inhibition of lipid autoxidation by human serum and its relation to serum proteins and α-tocopherol. Clin Sci 1974;47: 223-233.
9. Gutteridge JMC, Stocks J: Caeruloplasmin: Physiological and pathological perspectives. CRC Crit Rev Clin Lab Sci 1981;14: 257-329.
10. Davies KJA, Sevanian A, Muakkassah-Kelly SF, et al: Uric acid—iron ion complexes: A new aspect of the antioxidant functions of uric acid. Biochem J 1986;235: 747-754.
11. Hilderbrand DC, Fahim Z, James E, et al: Ceruloplasmin and alkaline phosphatase levels in cord serum of term, preterm, and physiologically jaundiced neonates. Am J Obstet Gynecol 1974; 118: 950-954.
12. Buffone GJ, Brett EM, Lewis SA, et al: Limitations of immunochemical measurement ceruloplasmin. Clin Chem 1979;25: 749-751.
13. Scott PH, Berger HM, Kenward C, et al: Effect of gestational age and intrauterine nutrition on plasma transferrin and iron in the newborn. Arch Dis Child 1975;50: 796-798.
14. Galet S, Schulman HM, Bard H: The postnatal hypotransferrinemia of early preterm newborn infants. Pediatr Res 1976;10: 118-120.
15. Saarinen UM, Siimes MA: Developmental changes in serum iron, total iron-binding capacity, and transferrin saturation in infancy. J Pediatr 1977;91: 875-877.
16. Siimes MA, Addiego JE, Dallman PR: Ferritin in serum: Diagnosis of iron deficiency and iron overload in infants and children. Blood 1974;43: 581-590.
17. Brittenham GM, Danish EH, Harris JW: Assessment of bone marrow and body iron stores: Old techniques and new technologies. Semin Hematol 1981;18: 194-221.
18. Shaw JCL: Iron absorption by the premature infant: The effect of transfusion and iron supplements on the serum ferritin levels. Acta Paediatr Scand 1982;299 (suppl): 83-89.
19. Lukens JN: Iron metabolism and iron deficiency anemia, in Miller DR, Baehner RL, McMillan CW, et al (eds): Blood Diseases of Infancy and Childhood. St Louis, CV Mosby Co, 1984, pp 115-146.
20. Ward PA, Till GO, Kunkel R, Beauchamp C: Evidence for role of hydroxyl radical in complement and neutrophil-dependent injury. J Clin Invest 1983;72: 789-801.
21. Babbs CF: Role of iron ions in the genesis of reperfusion injury following successful cardiopulmonary resuscitation: Preliminary data and a biochemical hypothesis. Ann Emerg Med 1985; 14: 777-783.
22. Editorial: Metal chelation therapy, oxygen radicals, and human disease. Lancet 1985; 1: 143-145.
23. Sullivan JL, Till GO, Ward PA: Iron depletion decreases lung injury after systemic complement activation, abstract. Fed Proc 1986;45: 452.
24. Andrews FJ, Morris CJ, Lewis EJ, et al: Effect of nutritional iron deficiency on acute and chronic inflammation. Ann Rheum Dis 1987; 46: 859-865.
25. Chandler DB, Barton JC, Briggs DD, et al: Effect of iron deficiency on bleomycin-induced lung fibrosis in the hamster. Am Rev Respir Dis 1988;137: 85-89.
26. Braughler JM, Duncan LA, Chase RL: The involvement of iron in lipid peroxidation: Importance of ferric to ferrous ratios in initiation. J Biol Chem 1986;261: 10282-10289.
27. Omene JA, Longe AC, Ihongbe JC, et al: Decreased umbilical cord serum ceruloplasmin concentrations in infants with hyaline membrane disease. J Pediatr 1981;99: 136-138.
28. Finch CA, Cook JD, Labbe RF, et al: Effect of blood donation on iron stores as evaluated by serum ferritin. Blood 1977;50: 441-447.
29. Herbert V: Recommended dietary intakes (RDI) of iron in humans. Am J Clin Nutr 1987; 45: 679-686.
30. Nemet K, Simonovits I: The biological role of lactoferrin. Haematologia 1985;18: 3-12.
31. Cunningham AS: Breast-feeding, antioxidants, and retinopathy of prematurity. Am J Obstet Gynecol 1987;156: 1040-1041.
32. Siimes MA, Vuori E, Kuitunen P: Breast milk iron-A declining concentration during the course of lactation. Acta Paediatr Scand 1979; 68: 29-31.
33. Fransson GB, Lönnerdal B: Iron in human milk. J Pediatr 1980;96: 380-384.
34. Jakobsson I, Lindberg T, Lothe L, et al: Human α-lactalbumin as a marker for macromolecular absorption. Gut 1986;27: 1029-1034.